# North China Pharmaceutical Huasheng Co., LTD – FDA Inspection, Sep 6, 2024

Source: https://www.keypedia.com/records/fda_inspections/north-china-pharmaceutical-huasheng-co-ltd/f218dae9-3562-49e8-9814-cae73bfe5d4f
Source feed: FDA_Inspections

> FDA inspection 1251737 of North China Pharmaceutical Huasheng Co., LTD, September 06, 2024. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1251737
- Company Name: North China Pharmaceutical Huasheng Co., LTD
- Inspection Date: 2024-09-06
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Monitoring of Marketed Animal Drugs, Feed, and Devices
- Product Type: Veterinary
- Center: Animal Drugs & Feeds
- Citation Count: 0

## Related Documents

- [FDA Inspection 1064484 - 2018-08-10](https://www.keypedia.com/records/fda_inspections/north-china-pharmaceutical-huasheng-co-ltd/c3ead95c-1b5e-4a02-8fc7-fcb50b9a56bd)
- FDA Inspection 950327 - 2015-09-11
- FDA Inspection 857285 - 2013-11-01
- FDA Inspection 708735 - 2010-11-11

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/saied-a-asbagh/215bfa90-995f-4310-baf3-cd9d37639b7b)

Company: https://www.keypedia.com/companies/north-china-pharmaceutical-huasheng-co-ltd/3ab06436-8d2e-4638-95a2-e80b11066d81